MicroRNA-150 A Novel Marker of Left Ventricular Remodeling After Acute Myocardial Infarction

被引:170
作者
Devaux, Yvan [1 ]
Vausort, Melanie [1 ]
McCann, Gerry P. [2 ,3 ]
Zangrando, Jennifer [1 ]
Kelly, Dominic [2 ,3 ]
Razvi, Naveed [2 ,3 ]
Zhang, Lu [1 ]
Ng, Leong L. [2 ,3 ]
Wagner, Daniel R. [1 ,4 ]
Squire, Iain B. [2 ,3 ]
机构
[1] Ctr Rech Publ Sante, Cardiovasc Res Lab, L-1150 Luxembourg, Luxembourg
[2] Univ Leicester, Leicester, Leics, England
[3] Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England
[4] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg
基金
美国国家卫生研究院;
关键词
biomarker; microRNA; myocardial infarction; remodeling; ACUTE CORONARY SYNDROMES; C-REACTIVE PROTEIN; HEART-FAILURE; CIRCULATING MICRORNAS; NATRIURETIC PEPTIDE; CARDIAC-HYPERTROPHY; EXPRESSION; BIOMARKERS; MATRIX-METALLOPROTEINASE-9; DISEASE;
D O I
10.1161/CIRCGENETICS.113.000077
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background- Left ventricular (LV) remodeling after acute myocardial infarction is associated with adverse prognosis. MicroRNAs (miRNAs) regulate the expression of several genes involved in LV remodeling. Our aim was to identify miRNAs associated with LV remodeling after acute myocardial infarction. Methods and Results- We studied 90 patients after first ST-segment-elevation acute myocardial infarction. A derivation cohort consisted of 60 patients characterized by echocardiography predischarge and at 6-month follow-up. Thirty patients characterized by magnetic resonance imaging predischarge and at 4-month follow-up were the validation cohort. Remodeling was defined as an increase in LV end-diastolic volume (Delta EDV>0) between discharge and follow-up. Circulating miRNAs were measured by microarrays and polymerase chain reaction. Using a systems-based approach, we identified several miRNAs potentially involved in LV remodeling. In the derivation cohort, one of these miRNAs, miR-150, was downregulated in patients with remodeling (Delta EDV>0) compared with patients without remodeling (Delta EDV <= 0). In the validation cohort, patients with remodeling had 2-fold lower levels of miR-150 than those without (P=0.03). miR-150 outperformed N-terminal pro-brain natriuretic peptide to predict remodeling (area under the receiver-operating characteristic curve of 0.74 and 0.60, respectively). miR-150 reclassified 54% (95% confidence interval, 5-102; P=0.03) of patients misclassified by N-terminal pro-brain natriuretic peptide and 59% (95% confidence interval, 9-108; P=0.02) of patients misclassified by a multiparameter clinical model, including age, sex, and admission levels of troponin I, creatine kinase, and N-terminal pro-brain natriuretic peptide. Conclusions- Low circulating levels of miR-150 are associated with LV remodeling after first ST-segment-elevation acute myocardial infarction. miR-150 has potential as a novel biomarker in this setting.
引用
收藏
页码:290 / 298
页数:9
相关论文
共 40 条
[1]
Differential Expression of MicroRNAs in Different Disease States [J].
Abdellatif, Maha .
CIRCULATION RESEARCH, 2012, 110 (04) :638-650
[2]
Systems-Based Approaches to Cardiovascular Biomarker Discovery [J].
Azuaje, Francisco J. ;
Dewey, Frederick E. ;
Brutsaert, Dirk L. ;
Devaux, Yvan ;
Ashley, Euan A. ;
Wagner, Daniel R. .
CIRCULATION-CARDIOVASCULAR GENETICS, 2012, 5 (03) :360-367
[3]
Biomarkers in heart failure [J].
Braunwald, Eugene .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2148-2159
[4]
DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[5]
Circulating MicroRNAs Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease? [J].
Creemers, Esther E. ;
Tijsen, Anke J. ;
Pinto, Yigal M. .
CIRCULATION RESEARCH, 2012, 110 (03) :483-495
[6]
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[7]
Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction [J].
Devaux, Yvan ;
Vausort, Melanie ;
Goretti, Emeline ;
Nazarov, Petr V. ;
Azuaje, Francisco ;
Gilson, Georges ;
Corsten, Maarten F. ;
Schroen, Blanche ;
Lair, Marie-Lise ;
Heymans, Stephane ;
Wagner, Daniel R. .
CLINICAL CHEMISTRY, 2012, 58 (03) :559-567
[8]
Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure [J].
Dewey, Frederick E. ;
Perez, Marco V. ;
Wheeler, Matthew T. ;
Watt, Clifton ;
Spin, Joshua ;
Langfelder, Peter ;
Horvath, Steve ;
Hannenhalli, Sridhar ;
Cappola, Thomas P. ;
Ashley, Euan A. .
CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (01) :26-U129
[9]
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure [J].
Divakaran, Vijay ;
Mann, Douglas L. .
CIRCULATION RESEARCH, 2008, 103 (10) :1072-U47
[10]
The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling [J].
Donners, Marjo M. P. C. ;
Beckers, Linda ;
Lievens, Dirk ;
Munnix, Imke ;
Heemskerk, Johan ;
Janssen, Ben J. ;
Wijnands, Erwin ;
Cleutjens, Jack ;
Zernecke, Alma ;
Weber, Christian ;
Ahonen, Cory L. ;
Benbow, Ulrike ;
Newby, Andrew C. ;
Noelle, Randolph J. ;
Daemen, Mat J. A. P. ;
Lutgens, Esther .
BLOOD, 2008, 111 (09) :4596-4604